Evidence map›Paper›PMID 41602742›Full record

ArticleBeilstein journal of organic chemistry2026

Circumventing Mukaiyama oxidation: selective S-O bond formation via sulfenamide-alcohol coupling.

Guoling Huang, Huarui Zhu, Shuting Zhou, Wanlin Zheng, Fangpeng Liang, Zhibo Zhao, Yifei Chen, Xunbo Lu

Abstract readLetter
In one paragraph

Article in Beilstein journal of organic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guoling HuangSchool of Chemistry and Chemical Engineering, Lingnan Normal University, Zhanjiang, 524048, China.
Huarui Zhu *School of Chemistry and Chemical Engineering, Lingnan Normal University, Zhanjiang, 524048, China.
Shuting Zhou *School of Chemistry and Chemical Engineering, Lingnan Normal University, Zhanjiang, 524048, China.
Wanlin Zheng *School of Chemistry and Chemical Engineering, Lingnan Normal University, Zhanjiang, 524048, China.
Fangpeng Liang *School of Chemistry and Chemical Engineering, Lingnan Normal University, Zhanjiang, 524048, China.
Zhibo ZhaoSchool of Chemistry and Chemical Engineering, Lingnan Normal University, Zhanjiang, 524048, China.
Yifei ChenSchool of Chemistry and Chemical Engineering, Lingnan Normal University, Zhanjiang, 524048, China.
Xunbo LuSchool of Chemistry and Chemical Engineering, Lingnan Normal University, Zhanjiang, 524048, China.ORCID https://orcid.org/0000-0002-6162-8294

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A selective and efficient method for the synthesis of sulfinimidate esters via an NBS-promoted oxidative coupling of sulfenamides with alcohols has been developed. This operationally simple, metal-free protocol uses inexpensive and readily available reagents, operates under mild conditions, exhibits a broad substrate scope and high chemoselectivity, and clearly distinguishes itself from classical Mukaiyama-type oxidations. The reaction is readily scalable to gram quantities and is applicable to late-stage functionalization of complex alcohols, including bioactive molecules such as RU58841. Moreover, chiral alcohols such as ʟ-menthol are well tolerated, affording diastereomeric sulfinimidate esters that can undergo stereospecific Grignard substitutions to furnish enantioenriched sulfilimines with up to 93% ee. These results demonstrate the potential of sulfinimidate esters as versatile intermediates for enantioselective S-C bond formation under mild and metal-free conditions.

Indexed as

asymmetric synthesislate-stage functionalizationselective oxidationsulfenamidessulfinimidate esters

Identifiers

PMID41602742
PMCPMC12834055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.